NITEGE-Expression in Meniscal Matrix. A New, Immunohistochemical Marker of Meniscal-Tissue Degeneration

Affordable Access

Download Read

NITEGE-Expression in Meniscal Matrix. A New, Immunohistochemical Marker of Meniscal-Tissue Degeneration

Authors
  • Per Knoess
  • Martin Jakobs
  • Mike Otto
  • Gunnar Möllenhoff1
  • Manfred Krukemeyer
  • Veit Krenn
Type
Published Article
Journal
Journal of Orthopaedics and Trauma
Publisher
Ashdin Publishing
Publication Date
Feb 18, 2011
Volume
1
Pages
1–7
Identifiers
DOI: 10.4303/jot/235377
Source
Ashdin
Keywords
License
Green

Abstract

Background. No marker reflecting the patho-biology of meniscal degeneration (MD) is established so far. NITEGE is a hexapeptide fragments produced when aggrecan is cleaved. Methods. In vitro IL-1 exposition of bovine menisci (n = 4) caused extracellular NITEGE deposits detected by immunofluorescence. A retrospective immunohistochemical analysis of (n = 60) patients after meniscectomy for NITEGE deposits was performed. MD was graded as follows: no/little (grade 0/1), medium (grade 2) or severe (grade 3). Results. NITEGE deposits in areas of degeneration were demonstrated in 55% of the patients with grade 2 or 3 MD (PPV & specificity 100%), while no extracellular NITEGE deposits in the menisci with grade 0 or 1 MD could be detected. Age correlated with NITEGE deposits (r = 0.46) and grade of MD (r = 0.48). NITEGE-positive cell density and size were significantly higher close to a tear (p < 0, 001). Interpretation. Extracellular NITEGE deposits may be regarded as markers of medium and severe MD and might be used in diagnostic histopathology.

Report this publication

Statistics

Seen <100 times
Downloaded <100 times